This chemical is primarily utilized in the development of pharmaceutical compounds, particularly as a key intermediate in the synthesis of antibiotics. Its structure is integral to the production of fluoroquinolone-based drugs, which are widely used to treat bacterial infections. The compound's unique fluorinated cyclopropyl group enhances its ability to inhibit bacterial DNA gyrase and topoisomerase IV, making it effective against a broad spectrum of bacteria. Its application is crucial in creating medications for respiratory, urinary tract, and skin infections, as well as in combating antibiotic-resistant strains. Additionally, it is employed in research to explore new therapeutic agents with improved efficacy and reduced side effects.